CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year
CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
An Entire Book Was Written in DNA—and You Can Buy It for $60
What may be the first commercially available book saved in DNA is the latest example of how consumers might use molecular ...